Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The new low-dose vaccine is one-fifth the size of ...
Not all children are eligible for the new Moderna COVID shots. Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but ...
The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is part of a ...